Skip to search formSkip to main contentSkip to account menu

poly(maleic acid-styrene)neocarzinostatin

Known as: SMANCS, copoly(styrene-maleic acid)neocarzinostatin, zinostatin stimalamer 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
A 65‐year‐old woman with liver injury was referred to our hospital in 1992. She was diagnosed with primary biliary cirrhosis (PBC… 
1998
1998
We report a Phase I/II clinical trial of poly-(styrene-co-maleyl-half-n-butylate)-neocarzinostatin (SMANCS) for intra-arterial… 
1990
1990
Neocarzinostatin (NCS), styrene-maleic acid copolymer-conjugated neocarzinostatin (SMANCS), and ricin exhibited cytotoxicity… 
1990
1990
Copoly(styrene-maleic acid)-conjugated neocarzinostatin (SMANCS), a lipophilic derivative of the proteinaceous antitumor… 
1988
1988
Poly (styrene-co-maleic acid)-conjugated neocarzinostatin, SMANCS, induced antiviral activities in the circulation of mice. The… 
Highly Cited
1987
Highly Cited
1987
The binding of a copoly(styrene-maleic acid)-conjugated neocarzinostatin (NCS) designated as smancs (Mr 16,000), and parental NCS… 
1987
1987
The effects of environmental pH on the binding and cytotoxicity of the antitumor proteins neocarzinostatin (NCS) and SMANCS… 
1982
1982
The organ specificity and pharmacokinetics of SMANCS, poly (maleic acid-styrene)-conjugated neocarzinostatin (NCS), were… 
1982
1982
Two advantages of the present therapeutic approach were described. Firstly, a selective deposition of lipiodol in tumor tissue…